Blog

Rahul Gosain: Hepatocellular Cancer series – Unresectable HCC with Rachna Shroff

oncbrothers.com

Nov 30, 2024, 17:26

Rahul Gosain: Hepatocellular Cancer series – Unresectable HCC with Rachna Shroff

Rahul Gosain, Director of Regional Infusion Services and Medical Director at Wilmot Cancer Institute, shared a post on LinkedIn:

“Hepatocellular Cancer series (1/4): Unresectable HCC with Rachna Shroff, MD, FASCO

IO/IO combos (VEGF or CTLA4) in 1L
AEs/Management

Full discussion:

‘The use of Immunotherapy in unresectable Hepatocellular Carcinoma (HCC)’

‘HCC podcast series part 1: The use of IO in unresectable HCC’

Also on the ‘Oncology Brothers’ podcast.”

Proceed to the video attached to the post.

More posts featuring Rahul Gosain.

Drs. Rohit Gosain and Rahul Gosain (aka Oncology Brothers), are medical oncologists/hematologists. Through their social media platforms like X/Twitter, they actively engage with their audience. With their own YouTube channel and podcast, they provide accessible resources for cancer patients and their families.

Additionally, their participation in live conferences ensures that cancer patients receive the best care closer to home, reflecting their commitment to advancing oncology and improving patient outcomes through education and outreach.

Rachna T. Shroff, MD, MS, FASCO is an Associate Director of Clinical Investigations at the University of Arizona Cancer Center (UACC). She is the co-leader of the Gastrointestinal Clinical Research Team. She is also the Associate Dean for Clinical and Translational Research for the University of Arizona College of Medicine – Tucson.

Prof. Shroff is the Hepatobiliary Subcommittee co-chair for the Southwest Oncology Group (SWOG), Chair for GI ASCO 2024 and member of the ASCO Nominating Committee. Her research focus is the development of novel therapies for pancreatic and hepatobiliary cancers.